The Cardiac & Vascular Institute Research Foundation

02/15/2024

Congratulations to Dr. Matheen Khuddus and team at The Cardiac & Vascular Institute in Gainesville, FL for being the first COSIRA-II center in the South to successfully complete a crossover for a COSIRA-II patient.

To learn more about the COSIRA-II trial and for a list of participating sites visit clinicaltrials.gov

ISI http://bit.ly/3iEq7fC
Caution: Investigational Device. Limited by United States and Canada law to investigational use.

09/07/2023

September is Peripheral Artery Disease (PAD) awareness month! TCAVI would like to take this time and shed some light on what PADs is and how to spot the signs of the chronic disease early. PADs is the narrowing or blockage of the vessels that carry blood from the heart to the extremities. This can lead to less blood flow to parts of your body and result in life threatening complications if left untreated. The American Heart Association has a set of simple questions to ask yourself to see if you might be at risk of developing PADs. Keep your answers to these questions in mind next time you talk with your doctor!

07/13/2023

Have you ever thought about working in Clinical Research? Check out the link below to find out how to apply for a position with us as a Research Coordinator. We would love to teach you all about the world of Cardiovascular Research!

The Cardiac & Vascular Institute is certified as a great place to work, and are always looking to add to the TCAVI team!

04/10/2023

Original Article from The New England Journal of Medicine — Transcatheter Arterialization of Deep Veins in Chronic Limb-Threatening Ischemia

04/13/2022

“A new study finds that people with heart disease…”

Putting Research Into Context
It is nearly impossible to listen to the evening news, scan the Internet or pick up a newspaper without hearing about the latest medical study. Even though these studies can make big headlines, most of us are left wondering what, if anything, it means to us or a loved one.

https://www.cardiosmart.org/topics/manage-your-care/putting-research-into-context

03/31/2022

A HUGE congratulations to The Cardiac & Vascular Institute Research Foundation’s Dr. Matheen Khuddus and Dr. Nasir Nawaz (pictured in the navy blue scrubs), The Cardiac & Vascular Institute and the Cath Lab Team for enrolling the FIRST patient in Florida, the 3rd patient in the world, in the randomized double-blind COSIRA II trial of the coronary sinus reducer vs sham in patients with obliterative CAD and refractory angina!

05/31/2021

We remember with gratitude and pride all who have served and protected our freedom. Today and everyday we celebrate, honor and remember 🇺🇸

05/03/2021

May is High Blood Pressure Awareness Month!

What is high blood pressure?
High blood pressure (or hypertension) is when your blood pressure, the force of blood flowing through your blood vessels, is consistently too high making. High blood pressure causes harm by increasing the workload of the heart and blood vessels — making them work harder and less efficiently. High Blood Pressure is one of the leading killers around the world as well as across the United States.

The Cardiac & Vascular Institute Research Foundation is currently participating in a global research study regarding resistant hypertension. If you or someone you know struggles to control your high blood pressure and have trouble reaching your blood pressure goal with a combination of medications, we may be able to help.

Call today to schedule a consult with one of our Hypertension Specialists. You could be a candidate for one of our groundbreaking trials.

04/28/2021

FIRST IN FLORIDA!
Our Structural Heart Disease Team was the first team in the state of Florida to implant the Edwards PASCAL CLASP II TR transcatheter device as a part of the Edwards Lifesciences PASCAL CLASP II TR Pivotal Clinical Trial. This clinical trial evaluates the device for the management of patients with tricuspid regurgitation who have been determined to be at intermediate or greater risk for tricuspid valve surgery by the Structural Heart Team.

Ours was the first site in Florida activated for this clinical trial and is now the first site in Florida to successfully perform this procedure. This new clinical trial offers those with tricuspid regurgitation a new, minimally invasive treatment option for a disease where few effective options are available for patients.

Contact us today to schedule an appointment with our Structural Heart Team.

03/22/2021

We are seeking a CRC to join the Team!
The Cardiac and Vascular Institute Research Foundation is involved in multiple trials targeting all aspects of cardiac and vascular disease.

Visit www.tcavi.com for information on our practice and to apply for this position.

03/15/2021

FIRST IN FLORIDA:

Structural Heart Team First Site in Florida to be Activated for Clinical Trial for Tricuspid Valve Repair Device

The tricuspid valve has been known as "the forgotten valve." Tricuspid valve disease has long plagued both patients and treating physicians because of the devastating consequences of the disease, and a lack of good therapeutic options to treat it. A new clinical trial and device being offered at by the Florida Structural Heart Disease Center (comprised of The Cardiac & Vascular Institute Research Foundation and Florida Heart & Lung Institute) at North Florida Regional Medical Center, will offer new hope to patients who previously may have suffered with a lack of options.

Learn more about this exciting new treatment opportunity for those with tricuspid valve disease here: https://www.tcavi.com/resources/1205/

03/15/2021

PRESS RELEASE: https://www.tcavi.com/resources/1205/

The Florida Structural Heart Disease Center at North Florida Regional Medical Center (NFRMC), together with The Florida Heart & Lung Institute (FHLI) and The Cardiac & Vascular Institute Research Foundation ( ), have announced that they are the first site activated in the state of Florida in the Edwards Lifesciences PASCAL CLASP II TR Pivotal Clinical Trial. This clinical trial will evaluate the PASCAL transcatheter device for the management of patients with tricuspid regurgitation who have been determined to be at intermediate or greater risk for tricuspid valve surgery by the Structural Heart Team.

03/01/2021

March is Women's History Month!

"As we celebrate the history of women in cardiology for women’s history month, it is important to emphasize women’s heart health as a part of that story. Although heart disease is the number one killer of women, cardiovascular disease was really thought of as a man’s disease until the last few decades."

https://www.acc.org/latest-in-cardiology/articles/intouch/2016/03/15/16/47/a-history-of-womens-heart-health

A History of Women’s Heart Health Mar 15, 2016 Perspectives Share via: Font Size A A A This post was authored by Nanette K. Wenger, MD, MACC, professor at the Emory University School of Medicine, director of the cardiac clinics at Grady Memorial Hospital and a member of ACC’s Women in Cardiology...

02/24/2021

ICYMI: Yesterday on North Florida Regional Medical Center's ASK A HEART DOC, 's Interventional Cardiologist Dr. Mark Tulli and FHLI's Cardiothoracic Surgeon Dr. Charles Klodell discussed heart valve disease, TAVR and the ground breaking clinical research trials the Structural Heart Team is currently participating in!

02/23/2021

ASK A HEART DOC- Valve Disease Awareness Day/Heart Month
Join us on Tuesday, February 23rd at 4:00 p.m. EST, on the North Florida Regional Medical Center page for an interactive conversation via Facebook LIVE with Dr. Charles Klodell, a cardiothoracic surgeon with the Florida Heart & Lung Institute and Dr. Mark Tulli, an interventional cardiologist with The Cardiac and Vascular Institute. The docs will be talking about Valve Disease Awareness Day, our Structural Heart Program and Heart Month. Be sure to tune in with your questions ready... the docs will be answering them LIVE!

01/12/2021

Statins, common cholesterol-lowering medications, may protect women’s hearts from damage caused during chemotherapy for early-stage breast cancer, according to new research published today in the Journal of the American Heart Association, an open access journal of the American Heart Association.

Research Highlights: Women who take statins, the common cholesterol-lowering medication, during chemotherapy with anthracyclines for early-stage breast cancer are half as likely to require emergency department visits or hospitalization for heart...